Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SAFS (Safescience, Inc.) formerly IGGI. Hot Potential -- Ignore unavailable to you. Want to Upgrade?

To: rocket who wrote (7)	4/27/1998 4:46:00 PM
From: Andrew G.	Respond to of 110

With respect to my inquiry today: Regarding the BioSciences agreement: "We will market the products in 1998 for the home and garden." Regarding Elexa and other compounds: " With the professional agricultural market we are now in major field tests in NZ , US and other countries." GBC 590 is in Phase I clinical trial. " I asked about earnings and 10k but as you I hope will understand, these things cannot be discussed in public online. I've been long on SAFS since I started the original IGGI thread and feel that time is on our side.